Glioblastoma with BRAFV600E mutation and numerous metastatic foci: a case report

Glioblastoma, the most malignant astrocytic tumour, is associated with limited survival and thus rare metastases. We analysed a particularly interesting case – a 51-year-old male diagnosed within 2 years with primary and recurrent glioblastoma, isocitrate dehydrogenase (IDH)-wild type, as well as wi...

Full description

Bibliographic Details
Main Authors: Karolina Janik, Waldemar Och, Marta Popeda, Kamila Rosiak, Joanna Peciak, Piotr Rieske, Kamil Kulbacki, Blazej Szostak, Agnieszka Parda, Ewelina Stoczynska-Fidelus
Format: Article
Language:English
Published: Termedia Publishing House 2019-03-01
Series:Folia Neuropathologica
Subjects:
Online Access:https://www.termedia.pl/Glioblastoma-with-BRAFV600E-mutation-and-numerous-metastatic-foci-a-case-report,20,36147,1,1.html
_version_ 1819103269310431232
author Karolina Janik
Waldemar Och
Marta Popeda
Kamila Rosiak
Joanna Peciak
Piotr Rieske
Kamil Kulbacki
Blazej Szostak
Agnieszka Parda
Ewelina Stoczynska-Fidelus
author_facet Karolina Janik
Waldemar Och
Marta Popeda
Kamila Rosiak
Joanna Peciak
Piotr Rieske
Kamil Kulbacki
Blazej Szostak
Agnieszka Parda
Ewelina Stoczynska-Fidelus
author_sort Karolina Janik
collection DOAJ
description Glioblastoma, the most malignant astrocytic tumour, is associated with limited survival and thus rare metastases. We analysed a particularly interesting case – a 51-year-old male diagnosed within 2 years with primary and recurrent glioblastoma, isocitrate dehydrogenase (IDH)-wild type, as well as with numerous extra-central nervous system (CNS) metastatic foci. Genetic material obtained from primary and recurrent tumours, as well as from pulmonary metastasis was analysed and compared at a molecular level. Next generation sequencing (NGS) analysis revealed BRAFV600E mutation, detected only in 2-5% of glioblastomas, in both the primary tumour and pulmonary metastases. Importantly, this mutation provides a possible therapeutic option as it constitutes a target for clinically approved inhibitors. This case study not only demonstrates a molecular comparison of primary, recurrent and metastatic glioblastoma, but also emphasizes the need for precise molecular diagnostics, which may facilitate treatment choice, especially in tumours currently lacking efficient treatment.
first_indexed 2024-12-22T01:47:46Z
format Article
id doaj.art-3805579c7ef248698199601441493995
institution Directory Open Access Journal
issn 1641-4640
1509-572X
language English
last_indexed 2024-12-22T01:47:46Z
publishDate 2019-03-01
publisher Termedia Publishing House
record_format Article
series Folia Neuropathologica
spelling doaj.art-3805579c7ef2486981996014414939952022-12-21T18:43:01ZengTermedia Publishing HouseFolia Neuropathologica1641-46401509-572X2019-03-01571727910.5114/fn.2019.8383336147Glioblastoma with BRAFV600E mutation and numerous metastatic foci: a case reportKarolina JanikWaldemar OchMarta PopedaKamila RosiakJoanna PeciakPiotr RieskeKamil KulbackiBlazej SzostakAgnieszka PardaEwelina Stoczynska-FidelusGlioblastoma, the most malignant astrocytic tumour, is associated with limited survival and thus rare metastases. We analysed a particularly interesting case – a 51-year-old male diagnosed within 2 years with primary and recurrent glioblastoma, isocitrate dehydrogenase (IDH)-wild type, as well as with numerous extra-central nervous system (CNS) metastatic foci. Genetic material obtained from primary and recurrent tumours, as well as from pulmonary metastasis was analysed and compared at a molecular level. Next generation sequencing (NGS) analysis revealed BRAFV600E mutation, detected only in 2-5% of glioblastomas, in both the primary tumour and pulmonary metastases. Importantly, this mutation provides a possible therapeutic option as it constitutes a target for clinically approved inhibitors. This case study not only demonstrates a molecular comparison of primary, recurrent and metastatic glioblastoma, but also emphasizes the need for precise molecular diagnostics, which may facilitate treatment choice, especially in tumours currently lacking efficient treatment.https://www.termedia.pl/Glioblastoma-with-BRAFV600E-mutation-and-numerous-metastatic-foci-a-case-report,20,36147,1,1.htmlglioblastoma brafv600e next generation sequencing
spellingShingle Karolina Janik
Waldemar Och
Marta Popeda
Kamila Rosiak
Joanna Peciak
Piotr Rieske
Kamil Kulbacki
Blazej Szostak
Agnieszka Parda
Ewelina Stoczynska-Fidelus
Glioblastoma with BRAFV600E mutation and numerous metastatic foci: a case report
Folia Neuropathologica
glioblastoma
brafv600e
next generation sequencing
title Glioblastoma with BRAFV600E mutation and numerous metastatic foci: a case report
title_full Glioblastoma with BRAFV600E mutation and numerous metastatic foci: a case report
title_fullStr Glioblastoma with BRAFV600E mutation and numerous metastatic foci: a case report
title_full_unstemmed Glioblastoma with BRAFV600E mutation and numerous metastatic foci: a case report
title_short Glioblastoma with BRAFV600E mutation and numerous metastatic foci: a case report
title_sort glioblastoma with brafv600e mutation and numerous metastatic foci a case report
topic glioblastoma
brafv600e
next generation sequencing
url https://www.termedia.pl/Glioblastoma-with-BRAFV600E-mutation-and-numerous-metastatic-foci-a-case-report,20,36147,1,1.html
work_keys_str_mv AT karolinajanik glioblastomawithbrafv600emutationandnumerousmetastaticfociacasereport
AT waldemaroch glioblastomawithbrafv600emutationandnumerousmetastaticfociacasereport
AT martapopeda glioblastomawithbrafv600emutationandnumerousmetastaticfociacasereport
AT kamilarosiak glioblastomawithbrafv600emutationandnumerousmetastaticfociacasereport
AT joannapeciak glioblastomawithbrafv600emutationandnumerousmetastaticfociacasereport
AT piotrrieske glioblastomawithbrafv600emutationandnumerousmetastaticfociacasereport
AT kamilkulbacki glioblastomawithbrafv600emutationandnumerousmetastaticfociacasereport
AT blazejszostak glioblastomawithbrafv600emutationandnumerousmetastaticfociacasereport
AT agnieszkaparda glioblastomawithbrafv600emutationandnumerousmetastaticfociacasereport
AT ewelinastoczynskafidelus glioblastomawithbrafv600emutationandnumerousmetastaticfociacasereport